RecruitingPhase 1NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Sponsor: Eli Lilly and Company
St Louis, MO · +22 more sites
Prostate Cancer clinical trials in St Louis, MO
37 recruiting prostate cancer studies with a site in St Louis, MO.
RecruitingNot applicableNCT07221825
Low-Count Quantitative SPECT for Men Treated With Radium-223
Sponsor: Washington University School of Medicine
St Louis, MO
RecruitingPhase 1 / Phase 2NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Sponsor: Parabilis Medicines, Inc.
St Louis, MO · +30 more sites
RecruitingPhase 1NCT07114601
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Sponsor: Eli Lilly and Company
St Louis, MO · +15 more sites
RecruitingPhase 4NCT07569926
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Sponsor: Blue Earth Diagnostics
St Louis, MO · +5 more sites
RecruitingPhase 3NCT07200830
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Sponsor: Alliance for Clinical Trials in Oncology
Saint Joseph, MO · St Louis, MO · +136 more sites
RecruitingPhase 2NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Sponsor: Daiichi Sankyo
St Louis, MO · +12 more sites
RecruitingPhase 1 / Phase 2NCT07594106
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
Sponsor: Regeneron Pharmaceuticals
St Louis, MO · +5 more sites
RecruitingPhase 1NCT05818683
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
Sponsor: Janssen Research & Development, LLC
St Louis, MO · +6 more sites
RecruitingPhase 3NCT07225946
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Janssen Research & Development, LLC
St Louis, MO · +58 more sites
RecruitingPhase 2 / Phase 3NCT06780670
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Sponsor: Novartis Pharmaceuticals
St Louis, MO · +34 more sites
RecruitingPhase 2NCT05011383
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Sponsor: VA Office of Research and Development
Kansas City, MO · St Louis, MO · +15 more sites
RecruitingNot applicableNCT05804318
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer
Sponsor: Varian, a Siemens Healthineers Company
St Louis, MO · +4 more sites
RecruitingPhase 1NCT06440005
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Sponsor: Angiex, Inc.
St Louis, MO · +6 more sites
RecruitingPhase 1NCT07545811
Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Janux Therapeutics
St Louis, MO · +5 more sites
RecruitingPhase 1NCT04221542
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Amgen
St Louis, MO · +24 more sites
RecruitingPhase 3NCT04423211
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Sponsor: ECOG-ACRIN Cancer Research Group
Bolivar, MO · Cape Girardeau, MO · +338 more sites
RecruitingNot applicableNCT07109427
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
Sponsor: Washington University School of Medicine
St Louis, MO
RecruitingPhase 1NCT06966024
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
Sponsor: Deciphera Pharmaceuticals, LLC
St Louis, MO · +7 more sites
RecruitingPhase 1NCT06910657
IDOV-Immune for Advanced Solid Tumors
Sponsor: ViroMissile, Inc.
St Louis, MO · +2 more sites
RecruitingPhase 1NCT06545942
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Sponsor: MOMA Therapeutics
St Louis, MO · +11 more sites
RecruitingPhase 3NCT07052214
PSMA PET Combined With MRI for the Detection of PCa
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
St Louis, MO · +15 more sites
RecruitingNot applicableNCT04420702
Diffusion Basis Spectrum Imaging of the Prostate
Sponsor: Washington University School of Medicine
St Louis, MO
RecruitingPhase 3NCT06592924
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Sponsor: Canadian Cancer Trials Group
City of Saint Peters, MO · Creve Coeur, MO · St Louis, MO · +371 more sites
RecruitingNot applicableNCT07296887
CARE Tool Study Aim 3
Sponsor: Washington University School of Medicine
Rolla, MO · St Louis, MO · +1 more sites
RecruitingNot applicableNCT00969111
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
Sponsor: Proton Collaborative Group
St Louis, MO · +5 more sites
RecruitingPhase 2NCT05422911
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Sponsor: Sun Pharmaceutical Industries Limited
St Louis, MO · +11 more sites
RecruitingPhase 2NCT03821246
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
Sponsor: David Oh
St Louis, MO · +1 more sites
RecruitingPhase 1 / Phase 2NCT03424850
Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy
Sponsor: Washington University School of Medicine
St Louis, MO
RecruitingPhase 1 / Phase 2NCT06267729
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
St Louis, MO · +12 more sites
RecruitingPhase 4NCT04373564
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Sponsor: Guerbet
St Louis, MO · +15 more sites
RecruitingPhase 3NCT06470243
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Sponsor: SWOG Cancer Research Network
Cape Girardeau, MO · Farmington, MO · +171 more sites
RecruitingPhase 2NCT06134232
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Sponsor: Dendreon
St Louis, MO · +30 more sites
Not yet recruitingPhase 1NCT07756593
Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate Cancer
Sponsor: Washington University School of Medicine
St Louis, MO
Not yet recruitingPhase 2NCT07723651
[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)
Sponsor: Washington University School of Medicine
St Louis, MO · +2 more sites
Not yet recruitingPhase 2NCT07635524
A Phase 2 Trial of 61Cu-NU101 PET/CT Compared Against Current Standard-of-care 18F-piflufolastat (Pylarify®) PET/CT.
Sponsor: Hoag Memorial Hospital Presbyterian
St Louis, MO · +1 more sites
Not yet recruitingPhase not listedNCT06194461
LTFU for All Cell and Gene Therapy Studies
Sponsor: AstraZeneca
St Louis, MO · +17 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.